TRUMY (Terumo) FFO


TRUMY Terumo Corp TRUMY
92 GF Score
Price $13.64
GF Value $19.40
Valuation Modestly Undervalued
View Full Analysis

What is Terumo FFO?

FFO (Funds from operations) only applies to REITs.

TRUMY
92GF Score
Terumo Corp TRUMY
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Terumo (TRUMY) Overvalued in 2026?

Based on GuruFocus' analysis, Terumo stock appears to be undervalued. The current stock price of $13.64 is trading 29.7% below its estimated GF Value™ of $19.40. GuruFocus considers Terumo to be Modestly Undervalued.

Key valuation signals for TRUMY:

  • FFO:
  • GF Value™: $19.40 vs. price of $13.64 (29.7% below fair value)
  • GF Score™: 92/100

No single metric tells the full story. See the TRUMY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Terumo Business Description

Address 2-44-1 Hatagaya, Shibuya-ku, Tokyo, JPN, 151-0072
Started as a clinical thermometer producer in Japan in 1921, Terumo is a comprehensive medical device player with a diversified global revenue. Its product portfolio includes prefilled syringes, insulin patch pumps, neurovascular or cardiac vascular interventional devices, and blood processing systems. As of 2025, the cardiac and vascular business is the largest segment, contributing over 60% of its total revenue. Geographically, North America is the largest region, with 38% of Terumo's revenue.
92GF Score

Get the complete analysis for TRUMY

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$13.64
Price
$19.40
GF Value